The Role of p53 and Microvessel Count in Lung Cancer Prognosis
Author Information
Author(s): G Fontanini, S Vignati, M Lucchi, A Mussi, A Calcinai, L Boldrini, S Chin, V Silvestri, CA Angeletti, F Basolo, G Bevilacqua
Primary Institution: University of Pisa
Hypothesis
The study investigates the prognostic impact of microvessel count and p53 protein overexpression in non-small-cell lung carcinoma (NSCLC) and their relationship with vascular endothelial growth factor (VEGF) expression.
Conclusion
The study concludes that microvessel count and p53 protein accumulation significantly impact the prognosis of NSCLC.
Supporting Evidence
- Microvessel count and p53 accumulation significantly affect metastatic involvement, recurrence, and death.
- High microvessel count is associated with shorter overall and disease-free survival.
- VEGF expression is significantly lower in p53-negative and lowly vascularized tumors.
Takeaway
This study found that the number of blood vessels in lung tumors and the presence of a specific protein can help predict how well a patient will do.
Methodology
The study analyzed tumor samples from 73 patients using immunohistochemical methods to assess p53 expression, microvessel count, and VEGF expression.
Participant Demographics
66 men and 7 women with a mean age of 63 years.
Statistical Information
P-Value
P = 0.0009; P = 0.01; P = 0.0001; P = 0.0003; P = 0.02
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website